• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register

AZD-7762

Product ID A985130
Cas No. 860352-01-8
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $55.70 In stock
25 mg $185.40 In stock
100 mg $618.00 In stock
Bulk Quote
Add to Wishlist

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

AZD-7762 is a selective inhibitor of checkpoint kinase (CHK) 1 and CHK2. It enhances sensitivity of urothelial carcinoma cells to gemcitabine through the inhibition of DNA repair checkpoints. It also works with gemcitabine to suppress the growth of KRAS-driven LKB1-deficient lung adenocarcinomas.

Product Info

Cas No.

860352-01-8

Purity

≥98%

Formula

C17H19FN4O2S

Formula Wt.

362.42

IUPAC Name

3-(Carbamoylamino)-5-(3-fluorophenyl)-N-[(3S)-3-piperidinyl]-2-thiophenecarboxamide

Synonym

AZD 7762, AZD7762

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

A985130 MSDS PDF

Info Sheet

A985130 Info Sheet PDF

References

Isono M., Hoffmann M., et al. Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine. J Exp Clin Cancer Res. 36(1):1 (2017). PMID: 28049532.

Liu Y., Li Y., et al. Gemcitabine and Chk1 Inhibitor AZD7762 Synergistically Suppress the Growth of Lkb1-Deficient Lung Adenocarcinoma. Cancer Res. 77(18):5068-76 (2017). PMID: 28754670.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2023 LKT Laboratories, All Rights Reserved - Products for research use only